Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02226965
What this trial is testing

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Sierra Oncology LLC - a GSK company 45
Testing effectiveness (Phase 2)Ended earlyNCT02361346
What this trial is testing

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Who this might be right for
Non-Hodgkin's B-cell LymphomaLeukemia, Lymphocytic, Chronic, B-CellSmall Lymphocytic Leukemia+3 more
Molecular Templates, Inc. 38
Early research (Phase 1)UnknownNCT05758610
What this trial is testing

A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients

Who this might be right for
NHL, AdultAML, Adult Recurrent
Shengke Pharmaceuticals (Jiangsu) Limited, China 60
Testing effectiveness (Phase 2)Looking for participantsNCT06552559
What this trial is testing

Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Lymphoma RecurrentB-cell Lymphoma RefractoryCNS Metastases
Samsung Medical Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03533283
What this trial is testing

An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Hoffmann-La Roche 211
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06845241
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Non-Hodgkin Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd. 68
Early research (Phase 1)Study completedNCT04774068
What this trial is testing

Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more
Walter Hanel 5
Testing effectiveness (Phase 2)WithdrawnNCT04456023
What this trial is testing

Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00967369
What this trial is testing

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
M.D. Anderson Cancer Center 20
Early research (Phase 1)Ended earlyNCT03471351
What this trial is testing

Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL

Who this might be right for
Classical Hodgkin Lymphoma
Rhizen Pharmaceuticals SA 2
Large-scale testing (Phase 3)Study completedNCT00312845
What this trial is testing

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Millennium Pharmaceuticals, Inc. 676
Testing effectiveness (Phase 2)Active Not RecruitingNCT05950165
What this trial is testing

Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Cho Pharma Inc. 37
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Very early researchLooking for participantsNCT06346912
What this trial is testing

CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

Who this might be right for
Acute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell
Zhejiang University 20
Not applicableStudy completedNCT00098566
What this trial is testing

Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaQuality of Life
Fred Hutchinson Cancer Center 36
Early research (Phase 1)Study completedNCT01088048
What this trial is testing

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma
Gilead Sciences 241
Large-scale testing (Phase 3)Ended earlyNCT00057343
What this trial is testing

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 400
Testing effectiveness (Phase 2)Ended earlyNCT00810576
What this trial is testing

Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT04640779
What this trial is testing

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Histiocytic and Dendritic Cell NeoplasmRecurrent Hodgkin LymphomaRecurrent Non-Hodgkin Lymphoma+5 more
Mayo Clinic 22
Early research (Phase 1)Not Yet RecruitingNCT07691450
What this trial is testing

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent Enteropathy-Associated T-Cell LymphomaRecurrent Follicular Helper T-Cell Lymphoma+23 more
City of Hope Medical Center 40
Next Page